广誉远(600771)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600771 广誉远

已收盘 09-07 15:00:00

{"stockData":{"symbol":"600771","market":"SH","secType":"STK","nameCN":"广誉远","latestPrice":13.86,"timestamp":1788764401000,"preClose":13.73,"halted":0,"volume":5444600,"delay":0,"changeRate":0.0095,"floatShares":488999999,"shares":488999999,"eps":0.1448,"marketStatus":"已收盘","change":0.13,"latestTime":"09-07 15:00:00","open":13.79,"high":13.92,"low":13.68,"amount":75244900,"amplitude":0.0175,"askPrice":13.86,"askSize":153,"bidPrice":13.85,"bidSize":317,"shortable":0,"etf":0,"ttmEps":0.1448,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788831000000},"marketStatusCode":5,"adr":0,"adjPreClose":13.73,"symbolType":"stock","openAndCloseTimeList":[[1788744600000,1788751800000],[1788757200000,1788764400000]],"highLimit":15.1,"lowLimit":12.36,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":489491141,"isCdr":false,"pbRate":4.07,"roa":"--","peRate":95.718232,"roe":"5.1%","epsLYR":0.13,"committee":-0.209581,"marketValue":6784000000,"turnoverRate":0.0111,"status":0,"floatMarketCap":6784000000},"requestUrl":"/m/hq/s/600771","defaultTab":"news","newsList":[{"id":"2665366601","title":"每周股票复盘：广誉远（600771）将召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366601","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366601?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:34","pubTimestamp":1788636852,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，广誉远报收于13.73元，较上周的13.98元下跌1.79%。本周，广誉远8月31日盘中最高价报13.98元。广誉远当前最新总市值67.21亿元，在中药板块市值排名29/66，在两市A股市值排名2515/5214。本周关注点公司公告汇总：广誉远将于2026年9月9日召开半年度业绩说明会，介绍上半年经营成果与财务指标。公司公告汇总广誉远中药股份有限公司将于2026年9月9日15:00-16:00通过网络互动方式召开2026年半年度业绩说明会，会议将在价值在线平台举行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","600771","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878107","title":"广誉远：公司未收到参会通知，因此未安排相关人员出席","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664878107?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:21","pubTimestamp":1788427268,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远09月03日在投资者关系平台上答复投资者关心的问题。公司未收到参会通知，因此未安排相关人员出席。公司始终结合业务发展需求，主动参与官方及行业权威机构组织的重要会议和产业交流活动，后续将持续关注山西省中医药产业发展动态，积极参与相关行业对接活动。相关经营信息请以公司官方披露为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300031014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0077","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664389013","title":"广誉远（600771）披露召开2026年半年度业绩说明会预告公告，9月2日股价下跌1.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664389013","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664389013?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:27","pubTimestamp":1788341262,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，广誉远报收于13.65元，较前一交易日下跌1.87%，最新总市值为66.82亿元。该股当日开盘13.91元，最高13.91元，最低13.62元，成交额达8279.31万元，换手率为1.23%。近日，广誉远中药股份有限公司发布关于召开2026年半年度业绩说明会的预告公告。公告显示，公司将于2026年9月9日15:00-16:00通过网络互动方式召开2026年半年度业绩说明会，会议将在价值在线平台举行。投资者可于2026年9月7日15:00前通过指定链接或微信小程序提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200030945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0077","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663804580","title":"每周股票复盘：广誉远（600771）Q2净利增35.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663804580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663804580?lang=zh_cn&edition=full","pubTime":"2026-08-30 09:04","pubTimestamp":1788051853,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，广誉远报收于13.98元，较上周的13.44元上涨4.02%。股本股东变化截至2026年6月30日，广誉远股东户数为6.16万户，较3月31日减少4363.0户，减幅为6.62%。公司公告汇总广誉远中药股份有限公司2026年半年度报告摘要显示，截至报告期末，公司总资产为2,532,407,757.14元，较上年度末增长3.92%；归属于上市公司股东的净资产为1,667,344,475.10元，同比增长2.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","600771","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740988","title":"广誉远（600771）2026年中报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740988","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662740988?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:06","pubTimestamp":1787781991,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期广誉远发布2026年中报。根据财报显示，广誉远营收净利润同比双双增长。截至本报告期末，公司营业总收入8.24亿元，同比上升5.78%，归母净利润8465.73万元，同比上升10.15%。按单季度数据看，第二季度营业总收入3.36亿元，同比下降7.19%，第二季度归母净利润1791.92万元，同比上升35.01%。财报体检工具显示：建议关注公司现金流状况建议关注公司应收账款状况本文数据来源于广誉远2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662744899","title":"股市必读：广誉远中报 - 第二季度单季净利润同比增长35.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662744899","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662744899?lang=zh_cn&edition=full","pubTime":"2026-08-27 04:06","pubTimestamp":1787774775,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年上半年归母净利润8465.73万元，同比上升10.15%；第二季度单季度归母净利润同比上升35.01%。2026年第二季度单季度主营收入3.36亿元，同比下降7.19%；单季度归母净利润1791.92万元，同比上升35.01%；单季度扣非净利润480.55万元，同比上升10.28%；负债率33.39%，毛利率66.8%。公司公告汇总广誉远中药股份有限公司2026年半年度报告摘要截至报告期末，公司总资产2,532,407,757.14元，较上年度末增长3.92%；归属于上市公司股东的净资产1,667,344,475.10元，同比增长2.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700009518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662766744","title":"股市必读：广誉远新发布《广誉远中药股份有限公司2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662766744","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662766744?lang=zh_cn&edition=full","pubTime":"2026-08-26 09:42","pubTimestamp":1787708525,"startTime":"0","endTime":"0","summary":"公司公告汇总：公司于8月24日召开第九届董事会第五次会议，全票审议通过《2026年半年度报告及摘要》。广誉远中药股份有限公司第九届董事会第五次会议决议公告公司于2026年8月24日召开第九届董事会第五次会议，应出席董事8名，实际出席8名，会议由董事长李晓军主持，审议通过《公司2026年半年度报告及摘要》，表决结果为同意8票、反对0票、弃权0票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600017390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0188","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662075154","title":"图解广誉远中报：第二季度单季净利润同比增长35.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662075154","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662075154?lang=zh_cn&edition=full","pubTime":"2026-08-26 02:31","pubTimestamp":1787682718,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远2026年中报显示，上半年度公司主营收入8.24亿元，同比上升5.78%；归母净利润8465.73万元，同比上升10.15%；扣非净利润7134.54万元，同比上升4.92%；其中2026年第二季度，公司单季度主营收入3.36亿元，同比下降7.19%；单季度归母净利润1791.92万元，同比上升35.01%；单季度扣非净利润480.55万元，同比上升10.28%；负债率33.39%，投资收益-46.38万元，财务费用47.26万元，毛利率66.8%。财报数据概要请见下图:本文数据来源于广誉远2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600005248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661826931","title":"广誉远：根植于传统中医“治未病”的养生文化理念","url":"https://stock-news.laohu8.com/highlight/detail?id=2661826931","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661826931?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:33","pubTimestamp":1787304787,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远08月21日在投资者关系平台上答复投资者关心的问题。更何况下面经销商了广誉远回复：您好，感谢您的关注与反馈。公司深耕中医药领域多年，始终根植于传统中医“治未病”的养生文化理念，依托传世经典名方的配伍智慧、道地药材的品质根基与国家级非遗传统炮制技艺，积淀形成产品的核心养生文化内涵。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100031667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600771","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660042716","title":"股市必读：广誉远（600771）8月19日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2660042716","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660042716?lang=zh_cn&edition=full","pubTime":"2026-08-20 01:48","pubTimestamp":1787161701,"startTime":"0","endTime":"0","summary":"截至2026年8月19日收盘，广誉远报收于13.55元，下跌1.17%，换手率1.48%，成交量7.27万手，成交额9891.31万元。董秘最新回复投资者： ②赋能经销商开展AI体质筛查，严格做好合规划分：项目仅做健康科普与体质辨识，不开展疾病诊断、不直接宣讲龟龄集药效，仅提示肾阳虚人群可咨询执业中医师后按需选用，完全避开处方药广告监管红线。当日关注点交易信息汇总：8月19日主力资金净流出1063.26万元，占总成交额10.75%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000001896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600771","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660441893","title":"广誉远：数字化团队已开展相关专业考量及论证","url":"https://stock-news.laohu8.com/highlight/detail?id=2660441893","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660441893?lang=zh_cn&edition=full","pubTime":"2026-08-19 17:39","pubTimestamp":1787132353,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远08月19日在投资者关系平台上答复投资者关心的问题。公司严格规范落实药品推广的相关监管规定，同时关注到消费者自主辨别中医体质存在一定门槛，易出现难以准确对症辨别的实际情况，目前数字化团队已开展相关专业考量及论证。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900030431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0077","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660444186","title":"广誉远：正就数字化赋能业务的监管规范性等开展论证","url":"https://stock-news.laohu8.com/highlight/detail?id=2660444186","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660444186?lang=zh_cn&edition=full","pubTime":"2026-08-19 17:39","pubTimestamp":1787132352,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远08月19日在投资者关系平台上答复投资者关心的问题。目前公司内部正就数字化赋能业务的监管规范性、中医AI算法的专业性与准确度、合规管控机制及线下终端联动落地路径等开展论证。公司始终严守合规经营底线，若推进相关数字化服务工具，将严格遵循药品监管相关法规要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900030430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0188","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658730389","title":"广誉远：半夏泻心汤颗粒定价综合考量多重因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2658730389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658730389?lang=zh_cn&edition=full","pubTime":"2026-08-12 17:36","pubTimestamp":1786527367,"startTime":"0","endTime":"0","summary":"半夏泻心汤颗粒是按古代经典名方目录管理的中药复方制剂药品而非传统饮片，公司产品定价综合考量产品组方原料、质量标准、生产质控、市场环境及患者用药可及性等多重因素，始终以产品临床价值与长期市场发展为导向，不存在单纯追求高端高价作为产品定位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200030392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0077","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996429","title":"广誉远：已建立多维度常态化管控机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658996429?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:30","pubTimestamp":1786440631,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远08月11日在投资者关系平台上答复投资者关心的问题。首先，公司始终高度重视终端合规经营与品牌声誉管理，已建立多维度常态化管控机制，持续规范经销商经营商业推广宣传行为，保护品牌声誉。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100028086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0188","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657596146","title":"股市必读：广誉远（600771）8月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2657596146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657596146?lang=zh_cn&edition=full","pubTime":"2026-08-07 01:21","pubTimestamp":1786036870,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘，广誉远报收于14.14元，下跌1.6%，换手率1.81%，成交量8.88万手，成交额1.26亿元。董秘最新回复投资者： 目前白酒拥有十二项国标香型，董香型以草本参与制曲为核心特征。恳请管理层对该定位方案予以研讨。龟龄集酒炮制所用原药粉是依托国家级非物质文化遗产升炼技艺打造，公司持续探索产品差异化品牌定位与市场传播路径，推进养生酒业务发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700001587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","600771","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655890876","title":"股市必读：广誉远（600771）7月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2655890876","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655890876?lang=zh_cn&edition=full","pubTime":"2026-07-30 01:29","pubTimestamp":1785346150,"startTime":"0","endTime":"0","summary":"截至2026年7月29日收盘，广誉远报收于14.64元，上涨2.45%，换手率1.65%，成交量8.06万手，成交额1.17亿元。董秘最新回复投资者： 董秘您好。控股股东依法行使权利、履行义务，保证上市公司独立性，保障经营层充分履职。投资者： 董秘您好，7月15日前公司未披露半年报业绩预告，结合一季报业绩推算预示二季度盈利环比承压。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000000816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","600771","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655127865","title":"广誉远：公司将结合自身发展实际持续深化终端精细化运营","url":"https://stock-news.laohu8.com/highlight/detail?id=2655127865","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655127865?lang=zh_cn&edition=full","pubTime":"2026-07-29 17:51","pubTimestamp":1785318670,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远07月29日在投资者关系平台上答复投资者关心的问题。下半年传统旺季来临，公司对于国药堂门店动销、龟龄集酒渠道拓展有哪些落地举措提振经营？公司将结合自身发展实际持续深化终端精细化运营，提升门店经营质效。龟龄集酒线上线下协同运营，全力推动业务持续深耕。根据已披露定期报告信息，龟龄集酒业务占整体营收比重较小，后续发展情况请以公司官方信息为准，注意投资风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900029759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0077","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655637658","title":"广誉远：公司持续推进经营管理团队补强工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2655637658","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655637658?lang=zh_cn&edition=full","pubTime":"2026-07-29 17:33","pubTimestamp":1785317608,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远07月29日在投资者关系平台上答复投资者关心的问题。公司持续推进经营管理团队补强工作，完善管理团队，相关事项正在推进中。控股股东依法行使权利、履行义务，保证上市公司独立性，保障经营层充分履职。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900029178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0188","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654052280","title":"每周股票复盘：广誉远（600771）拟用公积弥补亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2654052280","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654052280?lang=zh_cn&edition=full","pubTime":"2026-07-26 01:46","pubTimestamp":1785001573,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，广誉远报收于13.94元，较上周的15.04元下跌7.31%。本周，广誉远7月20日盘中最高价报15.29元。广誉远当前最新总市值68.24亿元，在中药板块市值排名28/66，在两市A股市值排名2303/5200。本周关注点公司公告汇总：广誉远拟使用母公司资本公积金728,341,393.03元弥补累计亏损。本次弥补亏损后，资本公积金将减少至2,121,063,674.59元，未分配利润为0元。公司依据相关规定通知债权人，债权人可在规定期限内申报债权，要求清偿债务或提供担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","600771","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653038135","title":"广誉远（600771）披露使用公积金弥补亏损通知债权人的公告，7月24日股价下跌4.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653038135","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653038135?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:15","pubTimestamp":1784902504,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，广誉远报收于13.94元，较前一交易日下跌4.06%，最新总市值为68.24亿元。近日，广誉远中药股份有限公司发布《关于使用公积金弥补亏损通知债权人的公告》。公告显示，公司于2026年4月21日和6月29日分别召开第九届董事会第三次会议及2025年年度股东会，审议通过使用母公司资本公积金728,341,393.03元弥补累计亏损的议案。公司依据相关规定通知债权人，债权人可在规定期限内申报债权，要求清偿债务或提供担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400041891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600771","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788820857604,"stockEarnings":[{"period":"1week","weight":0.0036},{"period":"1month","weight":-0.0301},{"period":"3month","weight":-0.0007},{"period":"6month","weight":-0.1914},{"period":"1year","weight":-0.3111},{"period":"ytd","weight":-0.2291}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.0019},{"period":"3month","weight":-0.0193},{"period":"6month","weight":-0.0486},{"period":"1year","weight":0.0315},{"period":"ytd","weight":-0.0091}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广誉远中药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"61557人(较上一季度减少6.62%)","perCapita":"7951股","listingDate":"1996-11-05","address":"山西省晋中市太谷区广誉远路1号","registeredCapital":"48949万元","survey":"　　广誉远中药股份有限公司的主营业务是中药产品的生产与销售。公司的主要产品是中药产品。公司获得了“山西精品”认定，六味地黄丸传统制作技艺及姜炭制作技艺入选晋中市非物质文化遗产名录。","listedPrice":4.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"广誉远(600771)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供广誉远(600771)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"广誉远,600771,广誉远股票,广誉远股票老虎,广誉远股票老虎国际,广誉远行情,广誉远股票行情,广誉远股价,广誉远股市,广誉远股票价格,广誉远股票交易,广誉远股票购买,广誉远股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"广誉远(600771)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供广誉远(600771)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}